December 6, read through the Holy Bible in a year.

3 John. The Apostle sent a greeting to Gaius, who was commended for his love and generosity, and urged to follow good people like Demetrius, but to avoid bad people like Diotrephes. The letter ends with a farewell greeting. That’s it.

Proverbs 25 is a collection of more proverbs of Solomon collected after his death during the reign of Hezekiah.

Psalm, 141, of David. A short Psalm telling that confession without compromise comes before God’s protection and victory over evildoers.

Psalm 142, of David. When all strength fails “The LORD is my only refuge.

Psalm 143, of David. There is hope, even in the deepest despair.

Psalm 144, of David. He is a man of war, but gives praise to God with a new song, for God is the one who grants victory.

December 5, read through the Holy Bible in a year.

2 John is a very short letter, greeting the elect lady with joy that she and some of her children walk in Christ’s commandments, but also warning her to beware of Antichrist deceivers.

Micah 5. The promise of the coming Messiah: “But thou, Bethlehem Ephratah, though thou be little among the thousands of Judah, yet out of thee shall he come forth unto me that is to be ruler in Israel; whose goings forth have been from of old, from everlasting.”  But first, God promised punishment of Israel’s injustice.

Micah 6. The LORD laid out His a case against Israel and how He will punish Israel’s injustice. One remedy: “He hath shewed thee, O man, what is good; and what doth the Lord require of thee, but to do justly, and to love mercy, and to walk humbly with thy God?

Micah 7. The prophet expressed deep sorrow for Israel’s sins, coupled with the hope that the nation will rise again and that God will forgive Israel.

Pfizer forced to release results from their Covid-19 vaccine, and the early results are horrific.

This document provides an integrated analysis of the cumulative post-authorization safety data, including U.S. and foreign post-authorization adverse event reports received through 28 February 2021.

The document reveals that within just 90 days after the EUA release of Pfizer’s mRNA vaccine, the company was already aware of voluntary adverse reaction reports that revealed 1,223 deaths and over 42,000 adverse reports describing a total of 158,893 adverse reactions. The reports originated from numerous countries, including the United States, United Kingdom, Italy, Germany, France, Portugal, Spain and other nations.

This image has an empty alt attribute; its file name is screenshot-2021-12-03-at-17-30-07-5-3-6-postmarketing-experience-1-pdf.png

Of special interest is what happens to pregnant and breastfeeding mothers

This is alarming, since a gestation period is 9 months, and these are snapshots the first 90 days after introducing the vaccine. The question that many women have, especially health care women that have seen what is going on is: How safe is this vaccine really? Will it cause infertility? Will it drastically increase stillbirth? Will it damage my child in the womb? We now have nearly a year of data, and no one comes out and assures us that none of these things are happening, just an increase in deaths, and a large number of adverse reactions.

The second set of questions are: How much worse is COVID-19 itself compared to the vaccine? Does COVID-19 cause infertility? Is blood clotting worse? It maybe that for children and young adults the vaccine is worse than COVID itself, other data seems to suggest so for people under 45 years of age.

This vaccine should be halted for people under age 45 until answers are given. There seems to be a benefit for older people, a substantially reduced death risk.

BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL
Page 1
APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST
1p36 deletion syndrome; 2-Hydroxyglutaric aciduria; 5’nucleotidase increased;

Acoustic neuritis; Acquired C1 inhibitor deficiency;

Acquired epidermolysis bullosa; Acquired epileptic aphasia;

Acute cutaneous lupus erythematosus; Acute disseminated encephalomyelitis;

Acute encephalitis with refractory, repetitive partial seizures;

Acute febrile neutrophilic dermatosis; Acute flaccid myelitis;

Acute haemorrhagic leukoencephalitis; Acute haemorrhagic oedema of infancy;

Acute kidney injury; Acute macular outer retinopathy;

Acute motor axonal neuropathy; Acute motor-sensory axonal neuropathy;

Acute myocardial infarction; Acute respiratory distress syndrome;

Acute respiratory failure; Addison’s disease; Administration site thrombosis;

Administration site vasculitis; Adrenal thrombosis;

Ageusia;Agranulocytosis; Air embolism;

Alanine aminotransferase abnormal; Alanine aminotransferase increased;

Alcoholic seizure; Allergic bronchopulmonary mycosis;

Allergic oedema; Alloimmune hepatitis; Alopecia areata; Alpers disease;

Alveolar proteinosis; Ammonia abnormal; Ammonia increased;

Amniotic cavity infection; Amygdalohippocampectomy; Amyloid arthropathy;

Amyloidosis; Amyloidosis senile; Anaphylactic reaction; Anaphylactic shock;

Anaphylactic transfusion reaction; Anaphylactoid reaction; Anaphylactoid shock;

Anaphylactoid syndrome of pregnancy; Angioedema; Angiopathic neuropathy;

Ankylosing spondylitis; Anosmia; Antiacetylcholine receptor antibody positive;

Anti-actin antibody positive; Anti-aquaporin-4 antibody positive;

Anti-basal ganglia antibody positive;

Anti-cyclic citrullinated peptide antibody positive;

Anti-epithelial antibody positive; Anti-erythrocyte antibody positive;

Anti-exosome complex antibody positive; Anti-GAD antibody negative;

Anti-GAD antibody positive; Anti-ganglioside antibody positive;

Antigliadin antibody positive;

Anti-glomerular basement membrane disease;

Anti-glycyl-tRNA synthetase antibody positive;

Anti-HLA antibody test positive; Anti-IA2 antibody positive;

Anti-insulin antibody increased; Anti-insulin antibody positive;

Anti-insulin receptor antibody increased; Anti-insulin receptor antibody positive;

Anti-interferon antibody negative; Anti-interferon antibody positive;

Anti-islet cell antibody positive; Antimitochondrial antibody positive;

Anti-muscle specific kinase antibody positive;

Anti-myelin-associated glycoprotein antibodies positive;

Anti-myelin-associated glycoprotein associated polyneuropathy;

Antimyocardial antibody positive; Anti-neuronal antibody positive;

Antineutrophil cytoplasmic antibody increased;

Antineutrophil cytoplasmic antibody positive;

Anti-neutrophil cytoplasmic antibody positive vasculitis;

Anti-NMDA antibody positive; Antinuclear antibody increased;

Antinuclear antibody positive; Antiphospholipid antibodies positive;

Antiphospholipid syndrome; Anti-platelet antibody positive;

Anti-prothrombin antibody positive; Antiribosomal P antibody positive;

Anti-RNA polymerase III antibody positive;

Anti-saccharomyces cerevisiae antibody test positive;

Anti-sperm antibody positive; Anti-SRP antibody positive; Antisynthetase syndrome;

Anti-thyroid antibody positive; Anti-transglutaminase antibody increased;

Anti-VGCC antibody positive; Anti-VGKC antibody positive;

Anti-vimentin antibody positive; Antiviral prophylaxis; Antiviral treatment;

Anti-zinc transporter 8 antibody positive; Aortic embolus; Aortic thrombosis;

Aortitis; Aplasia pure red cell; Aplastic anaemia; Application site thrombosis;

Application site vasculitis; Arrhythmia;Arterial bypass occlusion;

Arterial bypass thrombosis; Arterial thrombosis; Arteriovenous fistula thrombosis;

Arteriovenous graft site stenosis; Arteriovenous graft thrombosis;

Arteritis; Arteritis coronary; Arthralgia; Arthritis; Arthritis enteropathic; Ascites;

Aseptic cavernous sinus thrombosis; Aspartate aminotransferase abnormal;

Aspartate aminotransferase increased; Aspartate-glutamate-transporter deficiency;

AST to platelet ratio index increased; AST/ALT ratio abnormal; Asthma;

Asymptomatic COVID-19; Ataxia; Atheroembolism; Atonic seizures;

Atrophic thyroiditis; Atypical benign partial epilepsy; Atypical pneumonia; Aura;

Autoantibody positive;Autoimmune anaemia; Autoimmune aplastic anaemia;

Autoimmune arthritis; Autoimmune blistering disease; Autoimmune cholangitis;

Autoimmune colitis; Autoimmune demyelinating disease; Autoimmune dermatitis;

Autoimmune disorder; Autoimmune encephalopathy;

Autoimmune endocrine disorder; Autoimmune enteropathy;

Autoimmune eye disorder; Autoimmune haemolytic anaemia;

Autoimmune heparin-induced thrombocytopenia; Autoimmune hepatitis;

Autoimmune hyperlipidaemia; Autoimmune hypothyroidism;

Autoimmune inner ear disease; Autoimmune lung disease;

Autoimmune lymphoproliferative syndrome; Autoimmune myocarditis;

Autoimmune myositis; Autoimmune nephritis; Autoimmune neuropathy;

Autoimmune neutropenia; Autoimmune pancreatitis; Autoimmune pancytopenia;

Autoimmune pericarditis; Autoimmune retinopathy; Autoimmune thyroid disorder;

Autoimmune thyroiditis; Autoimmune uveitis;

Autoinflammation with infantile enterocolitis;

Autoinflammatory disease; Automatism epileptic;

Autonomic nervous system imbalance; Autonomic seizure; Axial spondyloarthritis;

Axillary vein thrombosis; Axonal and demyelinating polyneuropathy;

Axonal neuropathy; Bacterascites; Baltic myoclonic epilepsy; Band sensation;

Basedow’s disease; Basilar artery thrombosis; Basophilopenia;B-cell aplasia;

Behcet’s syndrome; Benign ethnic neutropenia;

Benign familial neonatal convulsions;

Benign familial pemphigus; Benign rolandic epilepsy;

Beta-2 glycoprotein antibody positive; Bickerstaff’s encephalitis;

Bile output abnormal; Bile output decreased; Biliary ascites;

Bilirubin conjugated abnormal; Bilirubin conjugated increased;

Bilirubin urine present; Biopsy liver abnormal; Biotinidase deficiency;

Birdshot chorioretinopathy; Blood alkaline phosphatase abnormal;

Blood alkaline phosphatase increased; Blood bilirubin abnormal;

Blood bilirubin increased; Blood bilirubin unconjugated increased;

Blood cholinesterase abnormal; Blood cholinesterase decreased;

Blood pressure decreased; Blood pressure diastolic decreased;

Blood pressure systolic decreased; Blue toe syndrome;

Brachiocephalic vein thrombosis; Brain stem embolism; Brain stem thrombosis;

Bromosulphthalein test abnormal; Bronchial oedema;

Bronchitis; Bronchitis mycoplasmal; Bronchitis viral;

Bronchopulmonary aspergillosis allergic; Bronchospasm; Budd-Chiari syndrome;

Bulbar palsy; Butterfly rash; C1q nephropathy; Caesarean section;

Calcium embolism; Capillaritis; Caplan’s syndrome; Cardiac amyloidosis;

Cardiac arrest; Cardiac failure; Cardiac failure acute; Cardiac sarcoidosis;

Cardiac ventricular thrombosis; Cardiogenic shock; Cardiolipin antibody positive;

Cardiopulmonary failure; Cardio-respiratory arrest; Cardio-respiratory distress;

Cardiovascular insufficiency; Carotid arterial embolus; Carotid artery thrombosis;

Cataplexy;Catheter site thrombosis;

Catheter site vasculitis;

Cavernous sinus thrombosis;

CDKL5 deficiency disorder;

CEC syndrome;

Cement embolism;

Central nervous system lupus;

Central nervous system vasculitis;

Cerebellar artery thrombosis;

Cerebellar embolism;

Cerebral amyloid angiopathy;

Cerebral arteritis;

Cerebral artery embolism;

Cerebral artery thrombosis;

Cerebral gas embolism;

Cerebral microembolism;

Cerebral septic infarct;

Cerebral thrombosis;

Cerebral venous sinus thrombosis;

Cerebral venous thrombosis;

Cerebrospinal thrombotic tamponade;

Cerebrovascular accident;

Change in seizure presentation;

Chest discomfort;

Child-Pugh-Turcotte score abnormal;

Child-Pugh-Turcotte score increased;

Chillblains;

Choking;

Choking sensation;

Cholangitis sclerosing;

Chronic autoimmune glomerulonephritis;

Chronic cutaneous lupus erythematosus;

Chronic fatigue syndrome;

Chronic gastritis;

Chronic inflammatory demyelinating polyradiculoneuropathy;

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids;

Chronic recurrent multifocal osteomyelitis;

Chronic respiratory failure;

Chronic spontaneous urticaria;

Circulatory collapse;

Circumoral oedema;

Circumoral swelling;

Clinically isolated syndrome;

Clonic convulsion;

Coeliac disease;

Cogan’s syndrome;

Cold agglutinins positive;

Cold type haemolytic anaemia;

Colitis;

Colitis erosive;

Colitis herpes;

Colitis microscopic;

Colitis ulcerative;

Collagen disorder;

Collagen-vascular disease;

Complement factor abnormal;

Complement factor C1 decreased;

Complement factor C2 decreased;

Complement factor C3 decreased;

Complement factor C4 decreased;

Complement factor decreased;

Computerised tomogram liver abnormal;

Concentric sclerosis;

Congenital anomaly;

Congenital bilateral perisylvian syndrome;

Congenital herpes simplex infection;

Congenital myasthenic syndrome;

Congenital varicella infection;

Congestive hepatopathy;

Convulsion in childhood;

Convulsions local;

Convulsive threshold lowered;

Coombs positive haemolytic anaemia;

Coronary artery disease;

Coronary artery embolism;

Coronary artery thrombosis;

Coronary bypass thrombosis;

Coronavirus infection;

Coronavirus test;

Coronavirus test negative;

Coronavirus test positive;

Corpus callosotomy;

Cough;

Cough variant asthma;

COVID-19;

COVID-19 immunisation;

COVID-19 pneumonia;

COVID-19 prophylaxis;

COVID-19 treatment;

Cranial nerve disorder;

Cranial nerve palsies multiple;

Cranial nerve paralysis;

CREST syndrome;

Crohn’s disease;

Cryofibrinogenaemia;

Cryoglobulinaemia;

CSF oligoclonal band present;

CSWS syndrome;

Cutaneous amyloidosis;

Cutaneous lupus erythematosus;

Cutaneous sarcoidosis;

Cutaneous vasculitis;

Cyanosis;

Cyclic neutropenia;

Cystitis interstitial;

Cytokine release syndrome;

Cytokine storm;

De novo purine synthesis inhibitors associated acute inflammatory syndrome;

Death neonatal;

Deep vein thrombosis;

Deep vein thrombosis postoperative;

Deficiency of bile secretion;

Deja vu;Demyelinating polyneuropathy;

Demyelination;

Dermatitis;

Dermatitis bullous;

Dermatitis herpetiformis;

Dermatomyositis;

Device embolisation;

Device related thrombosis;

Diabetes mellitus;

Diabetic ketoacidosis;

Diabetic mastopathy;

Dialysis amyloidosis;

Dialysis membrane reaction;

Diastolic hypotension;

Diffuse vasculitis;

Digital pitting scar;

Disseminated intravascular coagulation;

Disseminated intravascular coagulation in newborn;

Disseminated neonatal herpes simplex;

Disseminated varicella;

Disseminated varicella zoster vaccine virus infection;

Disseminated varicella zoster virus infection;

DNA antibody positive;Double cortex syndrome;

Double stranded DNA antibody positive;

Dreamy state;Dressler’s syndrome;

Drop attacks;

Drug withdrawal convulsions;

Dyspnoea;

Early infantile epileptic encephalopathy with burst-suppression;

Eclampsia;Eczema herpeticum;

Embolia cutis medicamentosa;

Embolic cerebellar infarction;

Embolic cerebral infarction;

Embolic pneumonia;

Embolic stroke;

Embolism;

Embolism arterial;

Embolism venous;

Encephalitis;

Encephalitis allergic;

Encephalitis autoimmune;

Encephalitis brain stem;

Encephalitis haemorrhagic;

Encephalitis periaxialis diffusa;

Encephalitis post immunisation;

Encephalomyelitis;

Encephalopathy;

Endocrine disorder;

Endocrine ophthalmopathy;

Endotracheal intubation;

Enteritis;Enteritis leukopenic;

Enterobacter pneumonia;

Enterocolitis;Enteropathic spondylitis;

Eosinopenia;

Eosinophilic fasciitis;

Eosinophilic granulomatosis with polyangiitis;

Eosinophilic oesophagitis;

Epidermolysis;

Epilepsy

;Epilepsy surgery;

Epilepsy with myoclonic-atonic seizures;

Epileptic aura;

Epileptic psychosis;

Erythema;

Erythema induratum;

Erythema multiforme;

Erythema nodosum;

Evans syndrome;

Exanthema subitum;

Expanded disability tatus scale score decreased;

Expanded disability status scale score increased;

Exposure to communicable disease

;Exposure to SARS-CoV-2;

Eye oedema;Eye pruritus;

Eye swelling;

Eyelid oedema;

Face oedema;

Facial paralysis;

Facial paresis;

Faciobrachial dystonic seizure;

Fat embolism;

Febrile convulsion;

Febrile infection-related epilepsy syndrome;

Febrile neutropenia;

Felty’s syndrome;

Femoral artery embolism;

Fibrillary glomerulonephritis;

Fibromyalgia;

Flushing;Foaming at mouth;

Focal cortical resection;

Focal dyscognitive seizures;

Foetal distress syndrome;

Foetal placental thrombosis;

Foetor hepaticus;

Foreign body embolism;

Frontal lobe epilepsy;

Fulminant type 1 diabetes mellitus;

Galactose elimination capacity test abnormal;

Galactose elimination capacity test decreased;

Gamma-glutamyltransferase abnormal;

Gamma-glutamyltransferase increased;

Gastritis herpes;

Gastrointestinal amyloidosis;

Gelastic seizure;

Generalised onset non-motor seizure;

Generalised tonic-clonic seizure;

Genital herpes;

Genital herpes simplex;

Genital herpes zoster;

Giant cell arteritis;

Glomerulonephritis;

Glomerulonephritis membranoproliferative;

Glomerulonephritis membranous;

Glomerulonephritis rapidly progressive;

Glossopharyngeal nerve paralysis;

Glucose transporter type 1 deficiency syndrome;

Glutamate dehydrogenase increased;

Glycocholic acid increased;

GM2 gangliosidosis;

Goodpasture’s syndrome;

Graft thrombosis;

Granulocytopenia;

Granulocytopenia neonatal;

Granulomatosis with polyangiitis;

Granulomatous dermatitis;

Grey matter heterotopia;

Guanase increased;

Guillain-Barre syndrome;

Haemolytic anaemia;

Haemophagocytic lymphohistiocytosis;

Haemorrhage;

Haemorrhagic ascites;

Haemorrhagic disorder;

Haemorrhagic pneumonia;

Haemorrhagic varicella syndrome;

Haemorrhagic vasculitis;

Hantavirus pulmonary infection;

Hashimoto’s encephalopathy;

Hashitoxicosis;

Hemimegalencephaly;

Henoch-Schonlein purpura;

Henoch-Schonlein purpura nephritis;

Hepaplastin abnormal;

Hepaplastin decreased;

Heparin-induced thrombocytopenia;

Hepatic amyloidosis;

Hepatic artery embolism;

Hepatic artery flow decreased;

Hepatic artery thrombosis;

Hepatic enzyme abnormal;

Hepatic enzyme decreased;

Hepatic enzyme increased;

Hepatic fibrosis marker abnormal;

Hepatic fibrosis marker increased;

Hepatic function abnormal;

Hepatic hydrothorax;

Hepatic hypertrophy;

Hepatic hypoperfusion;

Hepatic lymphocytic infiltration;

Hepatic mass;

Hepatic pain;

Hepatic sequestration;

Hepatic vascular resistance increased;

Hepatic vascular thrombosis;

Hepatic vein embolism;

Hepatic vein thrombosis;

Hepatic venous pressure gradient abnormal;

Hepatic venous pressure gradient increased;

Hepatitis;

Hepatobiliary scan abnormal;

Hepatomegaly;

Hepatosplenomegaly;

Hereditary angioedema with C1 esterase inhibitor deficiency;

Herpes dermatitis;

Herpes gestationis;

Herpes oesophagitis;

Herpes ophthalmic;

Herpes pharyngitis;

Herpes sepsis;

Herpes simplex;

Herpes simplex cervicitis;

Herpes simplex colitis;

Herpes simplex encephalitis

;Herpes simplex gastritis;

Herpes simplex hepatitis;

Herpes simplex meningitis;

Herpes simplex meningoencephalitis;

Herpes simplex meningomyelitis;

Herpes simplex necrotising retinopathy;

Herpes simplex oesophagitis;

Herpes simplex otitis externa;

Herpes simplex pharyngitis;

Herpes simplex pneumonia;

Herpes simplex reactivation;

Herpes simplex sepsis;

Herpes simplex viraemia;

Herpes simplex virus conjunctivitis neonatal;

Herpes simplex visceral;

Herpes virus infection;

Herpes zoster;

Herpes zoster cutaneous disseminated;

Herpes zoster infection neurological;

Herpes zoster meningitis;

Herpes zoster meningoencephalitis;

Herpes zoster meningomyelitis

Herpes zoster meningoradiculitis;

Herpes zoster necrotising retinopathy;

Herpes zoster oticus;

Herpes zoster pharyngitis;

Herpes zoster reactivation;

Herpetic radiculopathy;

Histone antibody positive;

Hoigne’s syndrome;

Human herpesvirus 6 encephalitis

Human herpesvirus 6 infection;

Human herpesvirus 6 infection reactivation;

Human herpesvirus 7 infection;

Human herpesvirus 8 infection;

Hyperammonaemia;

Hyperbilirubinaemia;

Hypercholia;ypergammaglobulinaemia benign monoclonal;

Hyperglycaemic seizure;

Hypersensitivity;

Hypersensitivity vasculitis;

Hyperthyroidism;

Hypertransaminasaemia;

Hyperventilation;Hypoalbuminaemia;

Hypocalcaemic seizure;

Hypogammaglobulinaemia;

Hypoglossal nerve paralysis;

Hypoglossal nerve paresis;

Hypoglycaemic seizure;

Hyponatraemic seizure;

Hypotension;

Hypotensive crisis;

Hypothenar hammer syndrome;

Hypothyroidism;

Hypoxia;

Idiopathic CD4 lymphocytopenia;

Idiopathic generalised epilepsy;

Idiopathic interstitial pneumonia;

Idiopathic neutropenia;

Idiopathic pulmonary fibrosis;

IgA nephropathy;

IgM nephropathy;

IIIrd nerve paralysis;

IIIrd nerve paresis;

Iliac artery embolism;

Immune thrombocytopenia;

Immune-mediated adverse reaction;

Immune-mediated cholangitis;

Immune-mediated cholestasis;

Immune-mediated cytopenia;

Immune-mediated encephalitis;

Immune-mediated encephalopathy;

Immune-mediated endocrinopathy;

Immune-mediated enterocolitis;

Immune-mediated gastritis;

Immune-mediated hepatic disorder;

Immune-mediated hepatitis;

Immune-mediated hyperthyroidism;

Immune-mediated hypothyroidism;

Immune-mediated myocarditis

;Immune-mediated myositis;

Immune-mediated nephritis;

Immune-mediated neuropathy

;Immune-mediated pancreatitis;

Immune-mediated pneumonitis;

Immune-mediated renal disorder;

Immune-mediated thyroiditis;

Immune-mediated uveitis;

Immunoglobulin G4 related disease;

Immunoglobulins abnormal;

Implant site thrombosis;

Inclusion body myositis;

Infantile genetic agranulocytosis;

Infantile spasms;

Infected vasculitis;

Infective thrombosis;

Inflammation;

Inflammatory bowel disease;

Infusion site thrombosis;

Infusion site vasculitis;

Injection site thrombosis;

Injection site urticaria;

Injection site vasculitis;

Instillation site thrombosis;

Insulin autoimmune syndrome;

Interstitial granulomatous dermatitis;

Interstitial lung disease;

Intracardiac mass;

Intracardiac thrombus;

Intracranial pressure increased;

Intrapericardial thrombosis;

Intrinsic factor antibody abnormal;

Intrinsic factor antibody positive;

IPEX syndrome;Irregular breathing;

IRVAN syndrome;

IVth nerve paralysis;

IVth nerve paresis;

JC polyomavirus test positive;

JC virus CSF test positive;

Jeavons syndrome;

Jugular vein embolism;

Jugular vein thrombosis;

Juvenile idiopathic arthritis;

Juvenile myoclonic epilepsy;

Juvenile polymyositis;

Juvenile psoriatic arthritis

;Juvenile spondyloarthritis;

Kaposi sarcoma inflammatory cytokine syndrome;

Kawasaki’s disease;

Kayser-Fleischer ring;

Keratoderma blenorrhagica;

Ketosis-prone diabetes mellitus;

Kounis syndrome;

Lafora’s myoclonic epilepsy;

Lambl’s excrescences;

Laryngeal dyspnoea;

Laryngeal oedema;

Laryngeal rheumatoid arthritis;

Laryngospasm;

Laryngotracheal oedema;

Latent autoimmune diabetes in adults;

LE cells present;

Lemierre syndrome;

Lennox-Gastaut syndrome;

Leucine aminopeptidase increased;

Leukoencephalomyelitis;

Leukoencephalopathy;

Leukopenia;

Leukopenia neonatal;

Lewis-Sumner syndrome;

Lhermitte’s sign;

Lichen planopilaris;

Lichen planus

;Lichen sclerosus;

Limbic encephalitis;

Linear IgA disease

;Lip oedema;

Lip swelling;

Liver function test abnormal;

Liver function test decreased;

Liver function test increased;

Liver induration;

Liver injury;

Liver iron concentration abnormal;

Liver iron concentration increased;

Liver opacity;

Liver palpable;

Liver sarcoidosis;

Liver scan abnormal;

Liver tenderness;

Low birth weight baby;

Lower respiratory tract herpes infection;

Lower respiratory tract infection;

Lower respiratory tract infection viral;

Lung abscess;

Lupoid hepatic cirrhosis;

Lupus cystitis;

Lupus encephalitis

;Lupus endocarditis;

Lupus enteritis;

Lupus hepatitis;

Lupus myocarditis

;Lupus myositis;

Lupus nephritis;

Lupus pancreatitis;

Lupus pleurisy;

Lupus pneumonitis;

Lupus vasculitis;

Lupus-like syndrome;

Lymphocytic hypophysitis;

Lymphocytopenia neonatal;

Lymphopenia;MAGIC syndrome;

Magnetic resonance imaging liver abnormal;

Magnetic resonance proton density fat fraction measurement;

Mahler sign;

Manufacturing laboratory analytical testing issue;

Manufacturing materials issue

;Manufacturing production issue;

Marburg’s variant multiple sclerosis;

Marchiafava-Bignami disease;

Marine Lenhart syndrome;

Mastocytic enterocolitis;

Maternal exposure during pregnancy;

Medical device site thrombosis;

Medical device site vasculitis;

MELAS syndrome;

Meningitis;

Meningitis aseptic;

Meningitis herpes;

Meningoencephalitis herpes simplex neonatal;

Meningoencephalitis herpetic;

Meningomyelitis herpes;

MERS-CoV test

;MERS-CoV test negative;

MERS-CoV test positive;

Mesangioproliferative glomerulonephritis;

Mesenteric artery embolism;

Mesenteric artery thrombosis;

Mesenteric vein thrombosis;

Metapneumovirus infection;

Metastatic cutaneous Crohn’s disease;

Metastatic pulmonary embolism;

Microangiopathy;

Microembolism;

Microscopic polyangiitis;

Middle East respiratory syndrome;

Migraine-triggered seizure;

Miliary pneumonia;

Miller Fisher syndrome;

Mitochondrial aspartate aminotransferase increased;

Mixed connective tissue disease;

Model for end stage liver disease score abnormal;

Model for end stage liver disease score increased;

Molar ratio of total branched-chain amino acid to tyrosine;

Molybdenum cofactor deficiency;

Monocytopenia;

Mononeuritis;

Mononeuropathy multiplex;

Morphoea;

Morvan syndrome;

Mouth swelling;

Moyamoya disease;

Multifocal motor neuropathy;

Multiple organ dysfunction syndrome;

Multiple sclerosis;

Multiple sclerosis relapse;

Multiple sclerosis relapse prophylaxis;

Multiple subpial transection;

Multisystem inflammatory syndrome in children;

Muscular sarcoidosis;

Myasthenia gravis;

Myasthenia gravis crisis;

Myasthenia gravis neonatal;

Myasthenic syndrome;

Myelitis;

Myelitis transverse;

Myocardial infarction;

Myocarditis;

Myocarditis post infection;

Myoclonic epilepsy;

Myoclonic epilepsy and ragged-red fibres;

Myokymia;Myositis;

Narcolepsy;

Nasal herpes;

Nasal obstruction;

Necrotising herpetic retinopathy;

Neonatal Crohn’s disease;

Neonatal epileptic seizure;

Neonatal lupus erythematosus;

Neonatal mucocutaneous herpes simplex;

Neonatal pneumonia;

Neonatal seizure;

Nephritis;

Nephrogenic systemic fibrosis;

Neuralgic amyotrophy;

Neuritis;

Neuritis cranial;

Neuromyelitis optica pseudo relapse;

Neuromyelitis optica spectrum disorder;

Neuromyotonia;

Neuronal neuropathy;

Neuropathy peripheral;

Neuropathy, ataxia, retinitis pigmentosa syndrome;

Neuropsychiatric lupus;

Neurosarcoidosis;

Neutropenia;

Neutropenia neonatal;

Neutropenic colitis;

Neutropenic infection;

Neutropenic sepsis;

Nodular rash;

Nodular vasculitis

;Noninfectious myelitis;

Noninfective encephalitis;

Noninfective encephalomyelitis;

Noninfective oophoritis;

Obstetrical pulmonary embolism;

Occupational exposure to communicable disease;

Occupational exposure to SARS-CoV-2;

Ocular hyperaemia;

Ocular myasthenia;

Ocular pemphigoid;

Ocular sarcoidosis;

Ocular vasculitis;

Oculofacial paralysis;

Oedema;Oedema bliste;r

Oedema due to hepatic disease;

Oedema mouth;

Oesophageal achalasia;

Ophthalmic artery thrombosis;

Ophthalmic herpes simplex;

Ophthalmic herpes zoster;

Ophthalmic vein thrombosis;

Optic neuritis;

Optic neuropathy;

Optic perineuritis;

Oral herpes;

Oral lichen planus;

Oropharyngeal oedema;

Oropharyngeal spasm;

Oropharyngeal swelling;

Osmotic demyelination syndrome;

Ovarian vein thrombosis;

Overlap syndrome;

Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection;

Paget-Schroetter syndrome;

Palindromic rheumatism;

Palisaded neutrophilic granulomatous dermatitis;

Palmoplantar keratoderma;

Palpable purpura;

Pancreatitis;

Panencephalitis;

Papillophlebitis;

Paracancerous pneumonia;

Paradoxical embolism;

Parainfluenzae viral laryngotracheobronchitis;

Paraneoplastic dermatomyositis;

Paraneoplastic pemphigus;

Paraneoplastic thrombosis;

Paresis cranial nerve;

Parietal cell antibody positive;

Paroxysmal nocturnal haemoglobinuria;

Partial seizures;

Partial seizures with secondary generalisation;

Patient isolation;

Pelvic venous thrombosis;emphigoid;

Pemphigus;Penile vein thrombosis;

Pericarditis;Pericarditis lupus;

Perihepatic discomfort;

Periorbital oedema;

Periorbital swelling;

Peripheral artery thrombosis;

Peripheral embolism;

Peripheral ischaemia;

Peripheral vein thrombus extension;

Periportal oedema;

Peritoneal fluid protein abnormal;

Peritoneal fluid protein decreased;

Peritoneal fluid protein increased;

Peritonitis lupus;

Pernicious anaemia;

Petit mal epilepsy;

Pharyngeal oedema;

Pharyngeal swelling;

Pityriasis lichenoides et varioliformis acuta;

Placenta praevia;

Pleuroparenchymal fibroelastosis;

Pneumobilia;

Pneumonia;

Pneumonia adenoviral;

Pneumonia cytomegaloviral;

Pneumonia herpes viral;

Pneumonia influenzal;

Pneumonia measles;

Pneumonia mycoplasmal;

Pneumonia necrotising;

Pneumonia parainfluenzae viral;

Pneumonia respiratory syncytial viral;

Pneumonia viral;

POEMS syndrome;

Polyarteritis nodosa;

Polyarthritis;

Polychondritis;

Polyglandular autoimmune syndrome type I;

Polyglandular autoimmune syndrome type II;

Polyglandular autoimmune syndrome type III;

Polyglandular disorder;

Polymicrogyria;

Polymyalgia rheumatica;

Polymyositis

;Polyneuropathy;

Polyneuropathy idiopathic progressive;

Portal pyaemia;

Portal vein embolism;

Portal vein flow decreased;

Portal vein pressure increased;

Portal vein thrombosis;

Portosplenomesenteric venous thrombosis;

Post procedural hypotension;

Post procedural pneumonia;

Post procedural pulmonary embolism;

Post stroke epilepsy;

Post stroke seizure;

Post thrombotic retinopathy;

Post thrombotic syndrome;

Post viral fatigue syndrome;

Postictal headache;

Postictal paralysis;

Postictal psychosis;

Postictal state;

Postoperative respiratory distress;

Postoperative respiratory failure;

Postoperative thrombosis;

Postpartum thrombosis;

Postpartum venous thrombosis;

Postpericardiotomy syndrome;

Post-traumatic epilepsy;

Postural orthostatic tachycardia syndrome;

Precerebral artery thrombosis;

Pre-eclampsia;

Preictal state;

Premature labour;

Premature menopause;

Primary amyloidosis;

Primary biliary cholangitis;

Primary progressive multiple sclerosis;

Procedural shock;

Proctitis herpes;

Proctitis ulcerative;

Product availability issue;

Product distribution issue;

Product supply issue;

Progressive facial hemiatrophy;

Progressive multifocal leukoencephalopathy;

Progressive multiple sclerosis;

Progressive relapsing multiple sclerosis;

Prosthetic cardiac valve thrombosis;

Pruritus;

Pruritus allergic;

Pseudovasculitis;

Psoriasis;

Psoriatic arthropathy

;Pulmonary amyloidosis;

Pulmonary artery thrombosis;

Pulmonary embolism;

Pulmonary fibrosis

;Pulmonary haemorrhage;

Pulmonary microemboli;

Pulmonary oil microembolism;

Pulmonary renal syndrome;

Pulmonary sarcoidosis;

Pulmonary sepsis;

Pulmonary thrombosis;

Pulmonary tumour thrombotic microangiopathy;

Pulmonary vasculitis;

Pulmonary veno-occlusive disease;

Pulmonary venous thrombosis;

Pyoderma gangrenosum;

Pyostomatitis vegetans;

Pyrexia;Quarantine;Radiation leukopenia;

Radiculitis brachial;

Radiologically isolated syndrome;

Rash;

Rash erythematous;

Rash pruritic;

Rasmussen encephalitis;

Raynaud’s phenomenon

;Reactive capillary endothelial proliferation;

Relapsing multiple sclerosis;

Relapsing-remitting multiple sclerosis;

Renal amyloidosis;

Renal arteritis;

Renal artery thrombosis;

Renal embolism;

Renal failure;

Renal vascular thrombosis;

Renal vasculitis;

Renal vein embolism;

Renal vein thrombosis;

Respiratory arrest;

Respiratory disorder;

Respiratory distress;

Respiratory failure;

Respiratory paralysis;

Respiratory syncytial virus bronchiolitis;

Respiratory syncytial virus bronchitis;

Retinal artery embolism;

Retinal artery occlusion;

Retinal artery thrombosis;

Retinal vascular thrombosis;

Retinal vasculitis;

Retinal vein occlusion;

Retinal vein thrombosis;

Retinol binding protein decreased;

Retinopathy;

Retrograde portal vein flow;

Retroperitoneal fibrosis;

Reversible airways obstruction;

Reynold’s syndrome;

Rheumatic brain disease;

Rheumatic disorder;

Rheumatoid arthritis;

Rheumatoid factor increased;

Rheumatoid factor positive;

Rheumatoid factor quantitative increased;

Rheumatoid lung;

Rheumatoid neutrophilic dermatosis;

Rheumatoid nodule;

Rheumatoid nodule removal;

Rheumatoid scleritis;

Rheumatoid vasculitis;

Saccadic eye movement;

SAPHO syndrome;

Sarcoidosis;

SARS-CoV-1 test;

SARS-CoV-1 test negative;

SARS-CoV-1 test positive;

SARS-CoV-2 antibody test;

SARS-CoV-2 antibody test negative;

SARS-CoV-2 antibody test positive;

SARS-CoV-2 carrier;

SARS-CoV-2 sepsis;

SARS-CoV-2 test;

SARS-CoV-2 test false negative;

SARS-CoV-2 test false positive;

SARS-CoV-2 test negative;

SARS-CoV-2 test positive;

SARS-CoV-2 viraemia;

Satoyoshi syndrome;

Schizencephaly;Scleritis;

Sclerodactylia;

Scleroderma;

Scleroderma associated digital ulcer;

Scleroderma renal crisis;

Scleroderma-like reaction;

Secondary amyloidosis;

Secondary cerebellar degeneration;

Secondary progressive multiple sclerosis;

Segmented hyalinising vasculitis;

Seizure;

Seizure anoxic;

Seizure cluster;

Seizure like phenomena;

Seizure prophylaxis;

Sensation of foreign body;

Septic embolus;

Septic pulmonary embolism;

Severe acute respiratory syndrome;

Severe myoclonic epilepsy of infancy;

Shock;

Shock symptom;

Shrinking lung syndrome;

Shunt thrombosis;

Silent thyroiditis;

Simple partial seizures;

Sjögren’s syndrome;

Skin swelling;

SLE arthritis;

Smooth muscle antibody positive;

Sneezing;

Spinal artery embolism;

Spinal artery thrombosis;

Splenic artery thrombosis;

Splenic embolism;

Splenic thrombosis;

Splenic vein thrombosis;

Spondylitis;

Spondyloarthropathy;

Spontaneous heparin-induced thrombocytopenia syndrome;

Status epilepticus;

Stevens-Johnson syndrome;

Stiff leg syndrome;

Stiff person syndrome;

Stillbirth;

Still’s disease;

Stoma site thrombosis;

Stoma site vasculitis;

Stress cardiomyopathy;

Stridor;

Subacute cutaneous lupus erythematosus;

Subacute endocarditis;

Subacute inflammatory demyelinating polyneuropathy;

Subclavian artery embolism;

Subclavian artery thrombosis;

Subclavian vein thrombosis;

Sudden unexplained death in epilepsy;

Superior sagittal sinus thrombosis;

Susac’s syndrome;

Suspected COVID-19;

Swelling;

Swelling face;

Swelling of eyelid;

Swollen tongue;

Sympathetic ophthalmia;

Systemic lupus erythematosus;

Systemic lupus erythematosus disease activity index abnormal;

Systemic lupus erythematosus disease activity index decreased;

Systemic lupus erythematosus disease activity index increased;

Systemic lupus erythematosus rash;

Systemic scleroderma;

Systemic sclerosis pulmonary;

Tachycardia;

Tachypnoea;

Takayasu’s arteritis;

Temporal lobe epilepsy;

Terminal ileitis;

Testicular autoimmunity;

Throat tightness;

Thromboangiitis obliterans;

Thrombocytopenia;

Thrombocytopenic purpura;

Thrombophlebitis;

Thrombophlebitis migrans;

Thrombophlebitis neonatal;

Thrombophlebitis septic;

Thrombophlebitis superficial;

Thromboplastin antibody positive;

Thrombosis;

Thrombosis corpora cavernosa;

Thrombosis in device;

Thrombosis mesenteric vessel;

Thrombotic cerebral infarction;

Thrombotic microangiopathy;

Thrombotic stroke;

Thrombotic thrombocytopenic purpura;

Thyroid disorder;

Thyroid stimulating immunoglobulin increased;

Thyroiditis;

Tongue amyloidosis

Tongue biting;

Tongue oedema;

Tonic clonic movements;

Tonic convulsion;

Tonic posturing;

Topectomy;

Total bile acids increased;

Toxic epidermal necrolysis;

Toxic leukoencephalopathy;

Toxic oil syndrome;

Tracheal obstruction;

Tracheal oedema;

Tracheobronchitis;

Tracheobronchitis mycoplasmal;

Tracheobronchitis viral;

Transaminases abnormal;

Transaminases increased;

Transfusion-related alloimmune neutropenia;

Transient epileptic amnesia;

Transverse sinus thrombosis;

Trigeminal nerve paresis;

Trigeminal neuralgia;

Trigeminal palsy;

Truncus coeliacus thrombosis;

Tuberous sclerosis complex;

Tubulointerstitial nephritis and uveitis syndrome;

Tumefactive multiple sclerosis;

Tumour embolism;

Tumour thrombosis;

Type 1 diabetes mellitus;

Type I hypersensitivity;

Type III immune complex mediated reaction;

Uhthoff’s phenomenon;

Ulcerative keratitis;

Ultrasound liver abnormal;

Umbilical cord thrombosis;

Uncinate fits;

Undifferentiated connective tissue disease;

Upper airway obstruction;

Urine bilirubin increased;

Urobilinogen urine decreased;

Urobilinogen urine increased;

Urticaria;

Urticaria papular;

Urticarial vasculitis;

Uterine rupture;

Uveitis;

Vaccination site thrombosis;

Vaccination site vasculitis;

Vagus nerve paralysis;

Varicella;

Varicella keratitis;

Varicella post vaccine;

Varicella zoster gastritis;

Varicella zoster oesophagitis;

Varicella zoster pneumonia;

Varicella zoster sepsis;

Varicella zoster virus infection;

Vasa praevia;Vascular graft thrombosis;

Vascular pseudoaneurysm thrombosis;

Vascular purpura;

Vascular stent thrombosis;

Vasculitic rash

;Vasculitic ulcer;

Vasculitis;

Vasculitis gastrointestinal;

Vasculitis necrotizing;

Vena cava embolism;

Vena cava thrombosis;

Venous intravasation;

Venous recanalisation;

Venous thrombosis;

Venous thrombosis in pregnancy;

Venous thrombosis limb;

Venous thrombosis neonatal;

Vertebral artery thrombosis;

Vessel puncture site thrombosis;

Visceral venous thrombosis;

VIth nerve paralysis;

VIth nerve paresis;

Vitiligo;

Vocal cord paralysis;

Vocal cord paresis;

Vogt-Koyanagi-Harada disease;

Warm type haemolytic anaemia;

Wheezing;

White nipple sign;

XIth nerve paralysis;

X-ray hepatobiliary abnormal;

Young’s syndrome;

Zika virus associated Guillain Barre syndrome

December 4, read through the Holy Bible in a year.

1 John 5. Being born of God and believing in the son of God means exercising obedience by Faith. The certainty of God’s witness is : “These things have I written unto you that believe on the name of the Son of God; that ye may know that ye have eternal life, and that ye may believe on the name of the Son of God.” There is  confidence and compassion in prayer, We must follow the true one and reject the false. And so the letter ends: “Little children, keep yourselves from idols. Amen.”

Micah 1. The prophet told of the coming judgment on Israel with mourning for Israel and Judah.

Micah 2. The prophet proclaimed woe to evildoers and lying prophets. After that Israel will be restored.

Micah 3. There was wicked rulers and wicked prophets. Micah still had full confidence in God.

Micah 4 speaks of the LORD’s future reign in Zion and Zion’s triumph.

December 3, read through the Holy Bible in a year.

1 John 4. Test the spirits. There is the spirit of God, and then there are many spirits of the Antichrist. Remember: “greater is he that is in you, than he that is in the world.” We know God through love and we see God through love, “We love him, because he first loved us.”

Proverbs 24 completes the sayings of the wise, and begins some more sayings of the wise. The two last verses are notable: “Yet a little sleep, a little slumber, a little folding of the hands to sleep:  So shall thy poverty come as one that travelleth; and thy want as an armed man.

Psalm 137. When the Jews were exiled into captivity they were forced to sing songs on their way. So somebody wrote a psalm about it. Compare that to when Paul and Silas were put in jail, they voluntarily sang songs of praise to God.

Psalm 138. David, as psalmist reminds us that God will honor His word and perform it to completion.

Psalm 139, of David. God knows everything, and He knows me much better than I know myself. Fittingly, the Psalm ends up with a song: “Search me, O God, and know my heart: try me, and know my thoughts: And see if there be any wicked way in me, and lead me in the way everlasting.

Psalm 140, of David. A heartfelt prayer for deliverance from evildoers.

December 2, read through the Holy Bible in a year.

1 John 3:11-24. We are children of God, or as the King James bible calls it “Behold, what manner of love the Father hath bestowed upon us, that we should be called the sons of God:” As children of God we do not sin,but it is important we love and show the outworking of love, for in it is the spirit of truth.

Jonah. The short but great story of Jonah, the famous solar eclipse of 763 B.C. the great solar eclipse of 2017, the coming eclipse of 2024 and the tearing down of statues.

Psalm 136 is called the Great Hallel (or Great Psalm of Praise). Each one of its 26 verses repeats the phrase, “His mercy endureth forever.”  It was sung responsively by the Levites and the assembly of people at both Solomon’s and Zerubbabel’s temple dedication and is now sometimes sung or recited at the Passover Seder.

December 1, read through the Holy Bible in a year.

1 John 3:1-10. We are children of God, or as the King James bible calls it “Behold, what manner of love the Father hath bestowed upon us, that we should be called the sons of God:” As children of God we do not continue to sin, for if we do we do not have the spirit of God in us.

Proverbs 23, Sayings of the Wise. Do not be a glutton, do not desire riches, do not be a moocher, do not argue with a fool, do not change ancient landmarks, do not withhold correction from a child, do not envy sinners because they are having fun, do not drink wine to excess, do not despise your mother when she is old, honor your father and mother, keep away from harlots, stay sober and do not succumb to alcohol.

Psalm 134 is the last of the songs of ascents. 3 verses short and to the point. Bless the Lord and He will bless you from Zion.

Psalm 135 is a Psalm of praise and thanksgiving to the uniqueness and superiority of the LORD, His name and all that He has done! Compare that to the worthless idols!

With the arrival of the new Omicron variant, are vaccines contributing to the spread of COVID-19?

November 3, 2021, San Diego, County Board of Supervisors meeting. Dr Scot Youngblood MD.

7:32 video of a doctor decimating the vaccine narrative at the San Diego county board of supervisors meeting. Worth the watch and forward to all.

This talk was given before the arrival of the Covid-19 Omicron variant. An ominous warning is coming from the Isle of Man Chief Minister Alf Cannan: “The greatest concern is that the virus has mutated to such an extent that our immune systems, trained by the vaccine, no longer recognize the virus and no longer trigger an immune response. This sort of variant is called an immune escape variant. Early evidence suggests there may be a higher infection risk with Omicron.”

If that is true, who should then get the vaccine, and should we push the booster shot?

Here is another ominous chart from Israel, having a very high vaccination rate among Jews, mostly with the Pfizer vaccine. The younger Arab population has only half the vaccination rate, and logically they have twice the COVID case rate. Israel was the earliest to vaccinate, and in August was ready to do booster shots. The results: More vaccination deaths.

The results were so alarming that they nearly stopped the booster shots, awaiting further evaluation

Looking at death risk versus age, it seems logical that older people benefit from the vaccine. This chart is from 2020, without any vaccines available.

But no we know so much more. The VAERS data, while abundant is not readily available, but U.K. and Scotland publicize the results, and it is abundantly clear that what we have here is vaccines that are failing. While they reduce the symptoms for a fully vaccinated person the vaccine do not immunize but instead acts as a potential mutation agent for the infected person, and thus once in a while a new variant is born.

The problem is that the vaccines are too specific, and allow mutations to escape, much like specific antibiotics, while very effective in the beginning, once in a while a resistant mutation develops, rendering the antibiotic useless. We need to go back to the drawing board and develop more broadband vaccines. The mRNA method of combating diseases has a bright future, not as a vaccine, but to fight cancer. The field is wide open, and the technology is well advanced.

Meanwhile we should go back and fight COVID-19 the old fashioned way, with proven medications suggested here. In the meantime, if you are fully vaccinated and over 45, it is o.k. to take the booster vaccine. It will increase the individual protection, but the transmission risk remains.

The Trans-Rocky-Mountain Aqueduct will save Lake Powell and Lake Mead, and rejuvenate the American South-west.

The American Southwest has always been subject to drought cycles, some worse than the one that is now devastating the area. Below is a very interesting presentation from ASU about a previous civilization in the Phoenix area, thriving and then gone. https://www.youtube.com/embed/II4Wb8SVxCE?version=3&rel=1&showsearch=0&showinfo=1&iv_load_policy=1&fs=1&hl=en&autohide=2&wmode=transparent Arizona State University presentation

Will it happen again?

The problem:

  1. Lake Powell and Lake Mead will be emptied in less than 10 years with the current usage pattern. Then what?
  2. The hydroelectric power from Lake Mead (and Lake Powell) is diminishing as the lakes are emptied.
  3. the aquifers are drawn down everywhere in the Southwest, but also the Ogallala Aquifer in Colorado and Kansas, and are at risk of being exhausted.
  4. The Colorado River water is too salty for good irrigation .
  5. The Colorado river no longer reaches the Gulf of California. Fishing and shrimp harvesting around the Colorado River Delta is no more.
  6. 40 million people depend on the Colorado River for drinking water. The population is still rising rapidly in the West. Will they have water in the future? Think 20 million future population growth in the next 40 years, people want to move there even with the current water problems.

The solution:

Build a Trans-Rocky-Mountain aqueduct from the Mississippi River to the San Juan River. In the first 391 miles the aqueduct joins the McClellan–Kerr Arkansas River Navigation System by adding the capability of pumping 7,500 cfs of water through 16 dams that service the locks. This will lead to reversing the flow of water during low flow. This also facilitates the navigation channel to be deepened from 9 feet to 12 feet to service fully loaded barges, a step authorized but not funded by Congress. The Arkansas river will then be capable of transporting 8 million acre-ft of water yearly through Arkansas, Oklahoma, Kansas, Colorado and New Mexico, supplying water from the Colorado river to Lake Powell. All that is needed to do in this stage is provide the dams and locks with a number of pumps and pump/generators to accommodate this, at a cost of less than 2 billion dollars. The next phase is pumping up water in the Arkansas river for 185 miles. To accommodate this there will be 17 small control dams built that are closed when normal pumping occurs and open during flood conditions. The cost for this segment, including pumps will be less than 3 billion dollars. The third segment is a 465 mile aqueduct to cross the Rocky Mountains much like the Central Arizona project but this aqueduct will carry three times more water 1.27 times the distance and raise the water four times higher. The original Central Arizona Project cost $4.7 billion in 1980’s money, the aqueduct part of the Trans-Rocky-Mountain aqueduct will cost around $50 Billion in 2021 money applying simple scaling up principles.

Power requirements for the 3 stages are 310 MW for the canal stage, 600MW for the river stage and 6.2 GW for the aqueduct stage. The aqueduct stage can be controlled by the power companies to shut off the pumps and provide 6.4 GW of virtual peak power for up to 5 hours a day on average, and each leg can be controlled individually since they are separated by large dams. There will be 64 one hundred MegaWatt LFTR (Liquid Fluoride salt Thorium Rector) power stations strategically stationed along the waterway providing pumping of water for 19 hours and providing virtual hydro-power output for on average 5 hours. There will also be 910 MW of power needed that is controlled by the river authorities.

The building cost of providing LFTR power should be around $2.50 per Watt of installed energy if a plant is built to manufacture via an assembly line a standardized version of 100 MW LFTR reactor core vessels assemblies capable of being transported on truck to the installation point. The total power cost should then be 16 billion dollars to build, and 5 cents per kWh or about 2.5 billion dollars a year to provide power.

The Mississippi River has a bad reputation for having polluted water, but since the clean water act the water quality has improved drastically. Fecal coli-form bacteria is down by a factor of more than 100, the water is now used all the way down to New Orleans for drinking water after treatment. The lead levels are down by a factor of 1000 or more since 1979. Plastic pollution and pharmaceutical pollution is still a problem, as is the case with most rivers. The Ph is back to around 8 and salt content is negligible. Mississippi water is good for irrigation, and usable for drinking water after treatment. The Arkansas River water quality is pretty good, good enough in Kaw Lake to be used for municipal water supply. Nitrates and phosphates are lower than in most Eastern rivers, Ph is around 8 and coli-bacteria low.

Most hydroelectric pumped storage was installed in the 70’s. Now natural gas plants provide most of the peak power. This aqueduct will add 6.4 GW to the U.S. pumped peak storage if virtual peak storage is included. By being pumped from surplus wind and solar energy as well as nuclear energy it is true “Green power”. Some people like that.

What follows is a description of each leg of the aqueduct. Legs 3, 4, 5 and 6 ends in a dam, which holds enough water to make each leg free to operate to best use of available electricity and provide peak power on demand.

Leg 1 of The Trans-Rocky-Mountain aqueduct. From the Mississippi river to Webbers Falls lock and dam. Total length 15miles of aqueduct and 335 miles of river. Cost of water 333 kWh per acre-ft.

Leg 2 of The Trans-Rocky-Mountain aqueduct. From Webbers Falls to Keystone Dam, a distance of about 75 miles that is river and 25 miles, which is canal. Cost of water 593 kWh per acre-ft.

Leg 3 of the Trans-Rocky-Mountain aqueduct. From Keystone Dam to Kaw Dam.The Keystone Lake is 38 miles long and the river part is about 110 miles. Cost of water 901 kWh per acre-ft.

Leg 4 of the Trans-Rocky-Mountain aqueduct. From Kaw Lake to John Martin Reservoir, a distance of about 200 miles. Cost of water 4,446 kWh per acre-ft.

Leg 5 of the Trans-Rocky-Mountain aqueduct. From John Martin Reservoir to Trinidad Lake, a distance of about 120 miles. Cost of water 7,300 kWh per acre-ft.

Leg 6 of the Trans-Rocky-Mountain aqueduct. From Trinidad Lake to Abiquiu Reservoir, a distance of 90 miles. Cost of water 7,910 kWh per acre-ft.

Leg 7 of the Trans-Rocky-Mountain aqueduct. From the Abiquiu Reservoir to the San Juan River, a distance of 55 miles. Cost of water 7,395 kWh per acre-ft.

November 30, read through the Holy Bible in a year.

1 John 2:18-29. The Apostle John explained there will come a last hour’s deception, so let the truth abide in You. Remember you are children of God.

Obadiah is a prophecy on the coming judgment on Edom, the descendants of Esau, Jacob’s brother. Edom mistreated his brother and this will lead to Israel’s final triumph.

Psalm 131. This is the shortest of the songs of ascents, only 3 verses. David showed his contentment in hoping in the Lord.

Psalm 132. This is the longest of the song of ascents, 18 verses. Remember God’s promise to David, to Israel and to the future Messiah.

Psalm 133, a Song of Ascents, of David. This Psalm too has only three verses, and the point of it is that it is good to dwell in unity.